Core Points - The recent announcement by President Trump regarding drug import tariffs will not apply to countries with which the U.S. has agreements that include drug provisions, benefiting major economies like the EU and Japan [1] - Drugs imported from the EU will incur a maximum tariff of 15% based on their framework agreement, while Japanese drugs will be taxed according to the agreed rates in the U.S.-Japan agreement [1] - The U.K. faces a different situation, with a potential 100% tariff on drugs exported to the U.S. due to the lack of an agreed-upon tariff rate between the U.S. and the U.K. [1] - Trump's announcement includes a 100% tariff on all "brand or patented drugs" unless companies are building or planning to build drug manufacturing facilities in the U.S. [1] - The U.S. has also reduced auto tariffs from 25% to 15% in alignment with a new trade agreement with the EU [1]
特朗普新药品关税政策细则出炉 欧盟与日本获豁免 英国药品或面临100%关税
智通财经网·2025-09-26 23:12